CBOE (CBOE) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates

07.02.25 15:30 Uhr

Werte in diesem Artikel
Aktien

198,05 EUR -0,75 EUR -0,38%

Indizes

6.026,0 PKT -57,6 PKT -0,95%

CBOE Global (CBOE) reported $524.5 million in revenue for the quarter ended December 2024, representing a year-over-year increase of 5.1%. EPS of $2.10 for the same period compares to $2.06 a year ago.The reported revenue represents a surprise of -0.61% over the Zacks Consensus Estimate of $527.73 million. With the consensus EPS estimate being $2.13, the EPS surprise was -1.41%.While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to determine their next move, some key metrics always offer a more accurate picture of a company's financial health.As these metrics influence top- and bottom-line performance, comparing them to the year-ago numbers and what analysts estimated helps investors project a stock's price performance more accurately.Here is how CBOE performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts: Average Revenue Per Contract by Product - Futures: $1.77 compared to the $1.76 average estimate based on seven analysts. Average Daily Volume by Product - Options - Multi-listed options: 11.63 million versus 11.28 million estimated by seven analysts on average. Average Daily Volume by Product - Options: 15.67 million versus 15.17 million estimated by seven analysts on average. Average Revenue Per Contract by Product - Options - Index options: $0.91 compared to the $0.90 average estimate based on seven analysts. Revenues- Access and capacity fees: $95 million compared to the $96.63 million average estimate based on seven analysts. The reported number represents a change of +7.1% year over year. Revenues- Other revenue: $23.20 million versus the four-analyst average estimate of $27.15 million. The reported number represents a year-over-year change of -7.2%. Revenues- Net transaction and clearing fees: $378.60 million compared to the $378.74 million average estimate based on four analysts. The reported number represents a change of +3.7% year over year. Revenues- Transaction and clearing fees: $762.60 million compared to the $754.97 million average estimate based on three analysts. The reported number represents a change of +3.8% year over year. Revenues- Futures- Transaction and clearing fees: $25.90 million versus the three-analyst average estimate of $25.67 million. The reported number represents a year-over-year change of +2%. Revenues- Global FX- Transaction and Clearing Fees: $16.60 million versus the three-analyst average estimate of $16.56 million. The reported number represents a year-over-year change of +5.1%. Revenues- Regulatory fees: $151.20 million compared to the $88.19 million average estimate based on three analysts. The reported number represents a change of +216.3% year over year. Revenues- Net transaction and clearing fees- Global FX: $16.20 million compared to the $16.27 million average estimate based on two analysts. View all Key Company Metrics for CBOE here>>>Shares of CBOE have returned +7.3% over the past month versus the Zacks S&P 500 composite's +1.9% change. The stock currently has a Zacks Rank #3 (Hold), indicating that it could perform in line with the broader market in the near term.Free Today: Profiting from The Future’s Brightest Energy SourceThe demand for electricity is growing exponentially. At the same time, we’re working to reduce our dependence on fossil fuels like oil and natural gas. Nuclear energy is an ideal replacement.Leaders from the US and 21 other countries recently committed to TRIPLING the world’s nuclear energy capacities. This aggressive transition could mean tremendous profits for nuclear-related stocks – and investors who get in on the action early enough.Our urgent report, Atomic Opportunity: Nuclear Energy's Comeback, explores the key players and technologies driving this opportunity, including 3 standout stocks poised to benefit the most.Download Atomic Opportunity: Nuclear Energy's Comeback free today.Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Cboe Global Markets, Inc. (CBOE): Free Stock Analysis ReportTo read this article on Zacks.com click here.Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks

Ausgewählte Hebelprodukte auf CBOE

Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf CBOE

NameHebelKOEmittent
NameHebelKOEmittent
Wer­bung

Quelle: Zacks

Nachrichten zu CBOE Holdings Inc

Wer­bung

Analysen zu CBOE Holdings Inc

DatumRatingAnalyst
10.07.2018CBOE BuyCompass Point
13.02.2018CBOE BuyDeutsche Bank AG
16.10.2017CBOE Sector PerformRBC Capital Markets
08.09.2017CBOE Equal WeightBarclays Capital
31.03.2017CBOE OutperformRBC Capital Markets
DatumRatingAnalyst
10.07.2018CBOE BuyCompass Point
13.02.2018CBOE BuyDeutsche Bank AG
31.03.2017CBOE OutperformRBC Capital Markets
02.05.2016CBOE OutperformRBC Capital Markets
09.12.2015CBOE OutperformRBC Capital Markets
DatumRatingAnalyst
16.10.2017CBOE Sector PerformRBC Capital Markets
08.09.2017CBOE Equal WeightBarclays Capital
27.09.2016CBOE Sector PerformRBC Capital Markets
08.01.2016CBOE HoldDeutsche Bank AG
06.01.2016CBOE NeutralUBS AG
DatumRatingAnalyst
02.05.2016CBOE UnderweightBarclays Capital

Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für CBOE Holdings Inc nach folgenden Kriterien zu filtern.

Alle: Alle Empfehlungen

Buy: Kaufempfehlungen wie z.B. "kaufen" oder "buy"
Hold: Halten-Empfehlungen wie z.B. "halten" oder "neutral"
Sell: Verkaufsempfehlungn wie z.B. "verkaufen" oder "reduce"